Enanta Pharmaceuticals (ENTA) Return on Capital Employed Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -300.00 |
| Dec 31, 2025 | -1,355.00 |
| Sep 30, 2025 | -2,645.00 |
| Jun 30, 2025 | -3,304.00 |
| Mar 31, 2025 | -3,750.00 |
| Dec 31, 2024 | -3,971.00 |
| Sep 30, 2024 | -4,486.00 |
| Jun 30, 2024 | -4,980.00 |
| Mar 31, 2024 | -5,607.00 |
| Dec 31, 2023 | -6,183.00 |
| Sep 30, 2023 | -5,619.00 |
| Jun 30, 2023 | -6,954.00 |
| Mar 31, 2023 | -6,424.00 |
| Dec 31, 2022 | -5,111.00 |
| Sep 30, 2022 | -4,412.00 |
| Jun 30, 2022 | -2,268.00 |
| Mar 31, 2022 | -2,585.00 |
| Dec 31, 2021 | -2,746.00 |
| Sep 30, 2021 | -3,809.00 |
| Jun 30, 2021 | -3,603.00 |
| Mar 31, 2021 | -3,398.00 |
| Dec 31, 2020 | -5,013.00 |
| Sep 30, 2020 | -6,156.00 |
| Jun 30, 2020 | -5,226.00 |
| Mar 31, 2020 | -6,808.00 |
| Dec 31, 2019 | -5,265.00 |
| Sep 30, 2019 | -443.00 |
| Jun 30, 2019 | -64.00 |
| Mar 31, 2019 | 3,769.00 |
| Dec 31, 2018 | 4,126.00 |
| Sep 30, 2018 | 1,527.00 |
| Jun 30, 2018 | 2,261.00 |